Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 11.3B | 10.6B | 11.5B | 11.4B |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | — | — | — | — |
| Other operating expenses | 3.5B | 3.3B | 3.2B | 2.9B |
| Operating income | — | — | — | — |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | — | — | — | — |
| Other income expense | — | — | — | — |
| Pretax income | 952.4M | 1.4B | 3.1B | 4.0B |
| Tax provision | 118.7M | 277.5M | 772.6M | 985.9M |
| Net income | 833.7M | 1.1B | 2.3B | 3.0B |
| Basic EPS | — | 0.6 | 1.2 | 1.6 |
| Diluted EPS | — | 0.6 | 1.2 | 1.5 |
| Basic average shares | — | 1.9B | 1.9B | 1.9B |
| Diluted average shares | — | 1.9B | 2.0B | 2.0B |
| EBITDA | — | — | — | — |
| Net income from continuing op. | — | — | — | — |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |